LEAF.TO - MedReleaf Corp.

Toronto - Toronto Delayed Price. Currency in CAD
24.60
+2.32 (+10.41%)
At close: 4:20PM EDT
Stock chart is not supported by your current browser
Previous Close22.28
Open22.10
Bid24.60 x 0
Ask24.75 x 0
Day's Range22.06 - 24.78
52 Week Range7.45 - 31.25
Volume1,180,220
Avg. Volume541,501
Market Cap2.496B
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.05
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.57
  • Investors Should Avoid Aurora Cannabis' Acquisition of MedReleaf Like the Plague
    Motley Fool4 days ago

    Investors Should Avoid Aurora Cannabis' Acquisition of MedReleaf Like the Plague

    This is a deal where both sides could actually lose.

  • Reefer Merger Madness: Aurora Cannabis, MedReleaf In Record Deal; Canopy Growth Plans NYSE Listing
    Investor's Business Daily7 days ago

    Reefer Merger Madness: Aurora Cannabis, MedReleaf In Record Deal; Canopy Growth Plans NYSE Listing

    Aurora Cannabis on Monday agreed to buy fellow Canadian pot stock MedReleaf for $2.5 billion, a record industry deal. Canada's Canopy Growth plans a NYSE listing.

  • Canada's Top Pot Millionaires Just Got Richer With Aurora Deal
    Bloomberg7 days ago

    Canada's Top Pot Millionaires Just Got Richer With Aurora Deal

    Some of Canada’s richest marijuana investors just got a little richer -- at least on paper. The biggest shareholders in Markham, Ontario-based pot grower MedReleaf Corp. now have stakes worth more than C$200 million ($156 million) each following Aurora Cannabis Inc.’s acquisition for about C$2.9 billion in stock, the largest deal in the sector. MedReleaf holders, including Gibraltar-based investor Tarik Ouass, along with Raymond Leach and Stephen Arbib have combined stakes worth about C$1.74 billion, based on the deal valuations.

  • Reuters7 days ago

    Aurora to buy MedReleaf for $2.5 bln in biggest ever pot deal

    Aurora Cannabis Inc will buy rival MedReleaf Corp for C$3.2 billion ($2.51 billion) in the biggest deal yet to unify major Canadian pot growers, as the country moves toward legalizing marijuana for recreational use. Canada's relaxed regulations, a mature industry and free-flowing capital have offered firms a unique opportunity to advance research without the legal and political risks that bog down growers in the United States and elsewhere. Canadian regulators have granted over 70 firms licenses to produce and sell medical marijuana, with more than half granted in 2017 or 2018.

  • Financial Times8 days ago

    [$$] Aurora Cannabis strikes $2.5bn deal for rival MedReleaf

    The deal gives Aurora a larger production footprint at a time when more governments around the globe are legalising recreational pot use. Terry Booth, the chief executive of the company, said the takeover “strengthens our capacity to service the rapidly expanding global medical cannabis markets”.

  • Better Marijuana Stock: MedReleaf vs. Cronos Group
    Motley Fool8 days ago

    Better Marijuana Stock: MedReleaf vs. Cronos Group

    They're two of the biggest Canadian marijuana stocks on the market, but which is the better pick for investors?

  • Two Canadian Companies Are Merging in the Biggest Weed Deal Ever
    Bloomberg8 days ago

    Two Canadian Companies Are Merging in the Biggest Weed Deal Ever

    Aurora Cannabis Inc. agreed to buy rival MedReleaf Corp. for about C$2.9 billion ($2.2 billion) in stock, the companies said Monday in a statement. Canadian marijuana growers are racing to gain market share as Prime Minister Justin Trudeau pushes to legalize recreational use this year. Aurora is leading the effort to consolidate the industry, having acquired more than 10 targets in the past two years.

  • Aurora to Buy MedReleaf for $2.5 Billion as Pot Laws Ease
    Bloomberg8 days ago

    Aurora to Buy MedReleaf for $2.5 Billion as Pot Laws Ease

    Aurora Cannabis Inc., a Canadian provider of medical marijuana, agreed to buy rival MedReleaf Corp. for about C$3.2 billion ($2.5 billion) in stock, gearing up for growth in demand for weed as governments ease restrictions on its use. The purchase values Markham, Ontario-based MedReleaf at C$29.44 a share, based on the average price of Aurora over the past 20 days, according to a statement Monday. Takeovers among Canada’s pot companies are heating up as Prime Minister Justin Trudeau pushes to legalize marijuana for recreational use this year.

  • CNW Group8 days ago

    Media Advisory - A Special Announcement from Aurora Cannabis and MedReleaf

    Media Advisory - A Special Announcement from Aurora Cannabis and MedReleaf

  • CNW Group8 days ago

    Aurora Cannabis to Acquire MedReleaf

    EDMONTON and MARKHAM, ON , May 14, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (ACB.TO) and MedReleaf Corp. ("MedReleaf") (LEAF.TO) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") whereby Aurora intends to acquire all of the issued and outstanding common shares of MedReleaf in an all-share transaction valued at approximately C$3.2 billion on a fully diluted basis (the "Transaction"). Under the terms of the Arrangement Agreement, holders of MedReleaf common shares will receive 3.575 common shares of Aurora for each MedReleaf common share held (the "Exchange Ratio").

  • A Marijuana Mega-Merger Between Aurora Cannabis and MedReleaf Would Be a Bad Idea
    Motley Fool13 days ago

    A Marijuana Mega-Merger Between Aurora Cannabis and MedReleaf Would Be a Bad Idea

    Sometimes bigger isn't better.

  • Motley Fool16 days ago

    Another Marijuana Stock Megadeal: Will Aurora Cannabis Buy MedReleaf?

    No. 2 plus No. 3 could result in No. 1 in the Canadian marijuana industry.

  • Reuters18 days ago

    PRESS DIGEST- Canada - May 4

    The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL ** The government of Canadian Prime ...

  • MedReleaf, Aurora Confirm Talks Amid Reports of Pot Merger
    Bloomberg18 days ago

    MedReleaf, Aurora Confirm Talks Amid Reports of Pot Merger

    Canadian marijuana producers MedReleaf Corp. and Aurora Cannabis Inc. said they’ve been in discussions amid speculation that the companies may combine. MedReleaf said Thursday in a statement that it’s had talks with companies including Aurora "regarding various alternatives.” Aurora said the same in a separate statement. The Globe and Mail reported Wednesday that MedReleaf has contacted larger companies about a sale and that Aurora was engaged in talks.

  • CNW Group18 days ago

    IIROC Trade Resumption - ACB; LEAF

    IIROC Trade Resumption - ACB; LEAF

  • CNW Group18 days ago

    MedReleaf responds to market rumors

    MARKHAM, ON , May 3, 2018 /CNW/ - MedReleaf Corp. ("MedReleaf" or the "Company") (LEAF.TO) is aware of a recent news article speculating as to a potential transaction involving Aurora Cannabis. As a general policy, MedReleaf does not publicly comment on unusual market activity, rumors or speculation in the marketplace or any potential transaction unless, and until, a binding legal agreement to effect that transaction has been signed. In response to a request by Investment Industry Regulatory Organization of Canada , the Company confirms that it engages from time to time in discussions with other industry players, including Aurora Cannabis, regarding various alternatives.

  • CNW Group18 days ago

    IIROC Trading Halt - ACB; LEAF

    IIROC Trading Halt - ACB; LEAF

  • Does MedReleaf Corp’s (TSE:LEAF) Past Performance Indicate A Weaker Future?
    Simply Wall St.19 days ago

    Does MedReleaf Corp’s (TSE:LEAF) Past Performance Indicate A Weaker Future?

    Measuring MedReleaf Corp’s (TSX:LEAF) track record of past performance is an insightful exercise for investors. It enables us to reflect on whether the company has met or exceed expectations, whichRead More...

  • CNW Group25 days ago

    MedReleaf partners with Niagara College to support cannabis production expertise in Canada

    MARKHAM, ON , April 27, 2018 /CNW/ - MedReleaf Corp. (LEAF.TO) ("MedReleaf" or the "Company"), Canada's  first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced that it has entered into a memorandum of understanding (MoU) with Niagara College to foster the development of cannabis production expertise in Canada through its Graduate Certificate program in Commercial Cannabis Production – Canada's first postsecondary credential in this emerging field.

  • PR Newswirelast month

    Global Cannabis Pioneer Tikun Olam and Ilera Healthcare Announce Pennsylvania Partnership to Deliver Science-Backed Cannabis Products to PA MMJ Patients

    PHILADELPHIA and NEW YORK , April 17, 2018 /PRNewswire/ --  Tikun Olam , the world leader in cannabis science, and Ilera Healthcare , Pennsylvania's premier medical marijuana cultivator, processor and ...

  • CNW Grouplast month

    MedReleaf adds PINs to its medical cannabis products to facilitate coverage and reimbursement under drug benefit plans

    MedReleaf adds PINs to its medical cannabis products to facilitate coverage and reimbursement under drug benefit plans

  • Reuterslast month

    Quebec signs weed supply agreements with six Canadian suppliers

    Hydropothecary Corp, Canopy Growth and Aphria Inc are among six companies that have signed agreements with Quebec's liquor board to supply the province with marijuana when Canada legalizes its recreational use this year, the companies said in separate statements on Wednesday. MedReleaf Corp, Aurora Cannabis and private equity firm Privateer Holdings-backed Tilray Canada are the other companies to sign the deal to supply the province's cannabis board, which will be created as a subsidiary of the liquor board to oversee marijuana sales.

  • CNW Grouplast month

    MedReleaf completes supply agreement with the Société des alcools du Québec for 8 tons of cannabis per year over three years

    MedReleaf completes supply agreement with the Société des alcools du Québec for 8 tons of cannabis per year over three years

  • Is MedReleaf Corp’s (TSE:LEAF) Balance Sheet A Threat To Its Future?
    Simply Wall St.last month

    Is MedReleaf Corp’s (TSE:LEAF) Balance Sheet A Threat To Its Future?

    While small-cap stocks, such as MedReleaf Corp (TSX:LEAF) with its market cap of CA$1.52B, are popular for their explosive growth, investors should also be aware of their balance sheet toRead More...

  • CNW Grouplast month

    MedReleaf announces senior leadership team additions bringing depth and experience from the global pharmaceutical industry

    MedReleaf announces senior leadership team additions bringing depth and experience from the global pharmaceutical industry